Association Between Late Age at Infectious Mononucleosis, Epstein-Barr Virus Antibodies, and Ovarian Cancer Risk

References

• Weiss NS, Cook LS, Farrow DC, Rosenblatt KA. Ovarian cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention, 2nd ed. New York: Oxford University Press; 1996. p. 1040–57.
   Google Scholar
• Yasui Y, Potter JD, Stanford JL, Rossing MA, Winget MD, Bronner M, Daling J. Breast cancer risk and ‘delayed’ primary Epstein-Barr virus infection. Cancer Epidemiol Biomarkers Prev 2001; 10: 9–16.
   PubMedGoogle Scholar
• Richardson A. Is breast cancer caused by late exposure to a common virus? Med Hypotheses 1997; 48: 491–7.
   PubMed Web of Science ®Google Scholar
• Niederman JC, Evans AS. Epstein-Barr Virus. In: Evans AS, Kaslow RA, eds. Viral infections of Humans: Epidemiology and Control, 4th ed. New York: Plenum Publishing Corp; 1997. p. 253–83.
   Google Scholar
• Katz BZ. Viral infections of the upper respiratory tract, infectious mononucleosis, and the chronic fatigue syndrome. In: Shulman ST, Phair JP, Peterson LR, Warren JR, eds. The Biological and Clinical Basis of Infectious Diseases, 5th ed. Philadelphia: WB Saunders Company; 1997. p. 102–6.
   Google Scholar
• Henderson B, Pike M, Bernstein L, Ross R. Breast cancer. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention, 2nd ed. New York: Oxford University Press; 1996. p. 893–919.
   Google Scholar
• Parkin D, Whelan S, Ferlay J, Raymond L, Young J. Cancer Incidence in Five Continents. Lyon: IARC; 1997.
   Google Scholar
• Daly M, Obrams GI. Epidemiology and risk assessment for ovarian cancer. Semin Oncol 1998; 25: 255–64.
   PubMed Web of Science ®Google Scholar
• Runnebaum IB, Stickeler E. Epidemiological and molecular aspects of ovarian cancer risk. J Cancer Res Clin Oncol 2001; 127: 73–9.
   PubMed Web of Science ®Google Scholar
• Cook LS, Kamb ML, Weiss NS. Perineal powder exposure and the risk of ovarian cancer. Am J Epidemiol 1997; 145: 459–65.
   PubMed Web of Science ®Google Scholar
• Hartge P, Brinton LA, Rosenthal JF, Cahill JI, Hoover RN, Waksberg J. Random digit dialing in selecting a population- based control group. Am J Epidemiol 1984; 120: 825–33.
   PubMed Web of Science ®Google Scholar
• Breslow NE, Day NE, Davis W. The analysis of case-control studies. Lyon: International Agency for Research on Cancer; 1980.
   Google Scholar
• SAS Institute I. SAS STAT user’s guide, version 6. 4th ed. Cary, NC: SAS Institute, Inc., 1990.
   Google Scholar
• Risch HA, Marrett LD, Jain M, Howe GR. Differences in risk factors for epithelial ovarian cancer by histological type. Results of a case-control study. Am J Epidemiol 1996; 144: 363–72.
   PubMed Web of Science ®Google Scholar
• Henle G, Henle W Immunofluorescence in cells derived from Burkitt’s lymphoma. J Bacteriol 1966; 91: 1248–56.
   PubMed Web of Science ®Google Scholar
• Horwitz CA, Henle W, Henle G, Rudnick H, Latts E. Longterm serological follow-up of patients for Epstein-Barr virus after recovery from infectious mononucleosis. J Infect Dis 1985; 151: 1150–3.
   Google Scholar
• Reedman BM, Klein G. Cellular localization of an Epstein-Barr virus (EBV)-associated complement-fixing antigen in producer and non-producer lymphoblastoid cell lines. Int J Cancer 1973; 11: 499–520.
   PubMed Web of Science ®Google Scholar
• Schooley R. Epstein-Barr Virus (Infectious Mononucleosis). In: Mandell GL, Douglas RG, Bennett JE, Dolin R, eds. Mandell, Douglas, and Bennett’s principles and practice of infectious diseases, 5th ed. Philadelphia: Churchill Livingstone; 2000. p. 1599–608.
   Google Scholar
• Wrensch M, Weinberg A, Wiencke J, Miike R, Barger G, Kelsey K. Prevalence of antibodies to four herpes viruses among adults with glioma and controls. Am J Epidemiol 2001; 154: 161–5.
   PubMed Web of Science ®Google Scholar
• Mueller NE, Evans AS, London WT. Viruses. In: Schottenfeld D, Fraumeni JF Jr, eds. Cancer Epidemiology and Prevention, 2nd ed. New York: Oxford University Press; 1996. p. 504–11.
   Google Scholar
• Storch GA. Infectious Mononucleosis. In: Storch GA, ed. Essentials of Diagnostic Virology. New York: Churchill Livingstone; 2000. p. 159–66.
   Google Scholar
• Okano M, Thiele GM, Davis JR, Grierson HL, Purtilo DT. Epstein-Barr virus and human diseases: recent advances in diagnosis. Clin Microbiol Rev 1988; 1: 300–12.
   Google Scholar
• Magrath I, Bhatia K. Breast cancer: a new Epstein-Barr virus- associated disease? J Natl Cancer Inst 1999; 91: 1349–50.
   PubMedGoogle Scholar
• Murray PG, Lissauer D, Junying J, Davies G, Moore S, Bell A, et al. Reactivity with a monoclonal antibody to Epstein-Barr virus (EBV) nuclear antigen 1 defines a subset of aggressive breast cancers in the absence of the EBV genome. Cancer Res 2003; 63: 2338–43.
   PubMed Web of Science ®Google Scholar
• Labrecque LG, Barnes DM, Fentiman IS, Griffin BE. Epstein- Barr virus in epithelial cell tumors: a breast cancer study. Cancer Res 1995; 55: 39–45.
   PubMed Web of Science ®Google Scholar
• Ziegler J. An unlikely link? Researchers probe viral role in breast cancer. J Natl Cancer Inst 1997; 89: 608–10.
   PubMedGoogle Scholar
• Bonnet M, Guinebretiere JM, Kremmer E, Grunewald V, Benhamou E, Contesso G, Joab I. Detection of Epstein-Barr virus in invasive breast cancers. J Natl Cancer Inst 2001; 91: 1376–81.
   Google Scholar
• Glaser SL, Ambinder RF, DiGiuseppe JA, Horn-Ross PL, Hsu JL. Absence of Epstein-Barr virus EBER-1 transcripts in an epidemiologically diverse group of breast cancers. Int J Cancer 1998; 75: 555–8.
   Google Scholar
• Kijima Y, Hokita S, Takao S, Baba M, Natsugoe S, Yoshinaka H, et al. Epstein-Barr virus involvement is mainly restricted to lymphoepithelial type of gastric carcinoma among various epithelial neoplasms. J Med Virol 2001; 64: 513–8.
   PubMed Web of Science ®Google Scholar
• McCall SA, Lichy JH, Bijwaard KE, Aguilera NS, Chu WS, Taubenberger JK. Epstein-Barr virus detection in ductal carcinoma of the breast. J Natl Cancer Inst 2001; 93: 148–50.
   PubMedGoogle Scholar
• Chu PG, Chang KL, Chen YY, Chen WG, Weiss LM. No significant association of Epstein-Barr virus infection with invasive breast carcinoma. Am J Pathol 2001; 159: 571–8.
   Google Scholar
• Vineis P, Miligi L, Crosignani P, Fontana A, Masala G, Nanni O, et al. Delayed infection, family size and malignant lymphomas. J Epidemiol Community Health 2000; 54: 907–11.
   PubMed Web of Science ®Google Scholar